Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42001354EBVENSG00000166006.14protein_codingKCNC2NoNo3747Q96PR1
TVIS10017977HBVENSG00000166006.14protein_codingKCNC2NoNo3747Q96PR1
TVIS10018012HBVENSG00000166006.14protein_codingKCNC2NoNo3747Q96PR1
TVIS10018057HBVENSG00000166006.14protein_codingKCNC2NoNo3747Q96PR1
TVIS10018107HBVENSG00000166006.14protein_codingKCNC2NoNo3747Q96PR1
TVIS10018122HBVENSG00000166006.14protein_codingKCNC2NoNo3747Q96PR1
TVIS10018243HBVENSG00000166006.14protein_codingKCNC2NoNo3747Q96PR1
TVIS10018330HBVENSG00000166006.14protein_codingKCNC2NoNo3747Q96PR1
TVIS10012771HBVENSG00000166006.14protein_codingKCNC2NoNo3747Q96PR1
TVIS10018025HBVENSG00000166006.14protein_codingKCNC2NoNo3747Q96PR1
TCGA Plot Options
Drug Information
GeneKCNC2
DrugBank IDDB06637
Drug NameDalfampridine
Target IDBE0004724
UniProt IDQ96PR1
Regulation Typeantagonist
PubMed IDs16472864
CitationsJudge SI, Bever CT Jr: Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther. 2006 Jul;111(1):224-59. Epub 2006 Feb 9.
GroupsApproved
Direct ClassificationAminopyridines and derivatives
SMILESNC1=CC=NC=C1
Pathways
PharmGKBPA166123389
ChEMBLCHEMBL284348